Xuan-Yu Chen

3.4k total citations · 1 hit paper
30 papers, 2.2k citations indexed

About

Xuan-Yu Chen is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Xuan-Yu Chen has authored 30 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Xuan-Yu Chen's work include Drug Transport and Resistance Mechanisms (6 papers), Ophthalmology and Visual Impairment Studies (4 papers) and Mitochondrial Function and Pathology (3 papers). Xuan-Yu Chen is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Ophthalmology and Visual Impairment Studies (4 papers) and Mitochondrial Function and Pathology (3 papers). Xuan-Yu Chen collaborates with scholars based in China, United States and Taiwan. Xuan-Yu Chen's co-authors include Jing‐Quan Wang, Zhe‐Sheng Chen, Zhuo‐Xun Wu, Dongya Zhang, Liuya Wei, Kejun Hou, Chuanxing Xiao, Jilin Li, Dan Zhu and Jagadish Koya and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecular Cancer and Nature Reviews Clinical Oncology.

In The Last Decade

Xuan-Yu Chen

28 papers receiving 2.2k citations

Hit Papers

Microbiota in health and ... 2022 2026 2023 2024 2022 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xuan-Yu Chen 1.3k 403 283 258 236 30 2.2k
Ceylan Tanes 1.1k 0.8× 244 0.6× 285 1.0× 233 0.9× 155 0.7× 47 1.7k
Yiwen Cheng 1.3k 1.0× 416 1.0× 282 1.0× 151 0.6× 221 0.9× 50 2.1k
Evan Brady 1.4k 1.1× 452 1.1× 270 1.0× 313 1.2× 176 0.7× 5 1.9k
Andrew B. Shreiner 1.2k 1.0× 448 1.1× 449 1.6× 329 1.3× 186 0.8× 17 2.3k
Jeongho Park 1.4k 1.1× 494 1.2× 362 1.3× 654 2.5× 189 0.8× 50 2.5k
Weiwei Luo 1.5k 1.1× 280 0.7× 237 0.8× 243 0.9× 131 0.6× 52 2.3k
Hannah Fehlner-Peach 1.4k 1.1× 491 1.2× 386 1.4× 370 1.4× 169 0.7× 8 2.2k
Sajad Karampoor 1.3k 1.1× 266 0.7× 514 1.8× 294 1.1× 190 0.8× 72 2.5k
Léon Zheng 2.0k 1.5× 542 1.3× 356 1.3× 227 0.9× 165 0.7× 19 2.7k
Chuanxing Xiao 1.9k 1.5× 617 1.5× 435 1.5× 152 0.6× 189 0.8× 43 2.8k

Countries citing papers authored by Xuan-Yu Chen

Since Specialization
Citations

This map shows the geographic impact of Xuan-Yu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan-Yu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan-Yu Chen more than expected).

Fields of papers citing papers by Xuan-Yu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuan-Yu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan-Yu Chen. The network helps show where Xuan-Yu Chen may publish in the future.

Co-authorship network of co-authors of Xuan-Yu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xuan-Yu Chen. A scholar is included among the top collaborators of Xuan-Yu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuan-Yu Chen. Xuan-Yu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xuan-Yu, Xinyuan Chen, Zhili Chen, et al.. (2025). Associations between CAG repeat size, brain and spinal cord volume loss, and motor symptoms in spinocerebellar ataxia type 3: a cohort study. Orphanet Journal of Rare Diseases. 20(1). 35–35. 1 indexed citations
2.
Ge, Minghua, Xuan-Yu Chen, Ping Huang, et al.. (2025). Understanding and overcoming multidrug resistance in cancer. Nature Reviews Clinical Oncology. 22(10). 760–780. 10 indexed citations
3.
Chen, Xuan-Yu, et al.. (2025). Axial length as a predictor of myopic macular degeneration: a meta-analysis and clinical study. Eye. 39(10). 2073–2082. 1 indexed citations
4.
5.
Chen, Xuan-Yu, Xintong Yu, Chunyu Huang, et al.. (2024). Apolipoprotein E epsilon4 allele is associated with better performance language and visual memory in spinocerebellar ataxia type 3. European Journal of Neurology. 32(1). e70017–e70017.
6.
Li, Chia-Ying, et al.. (2024). An acridone based fluorescent dye for lipid droplet tracking and cancer diagnosis. Journal of Photochemistry and Photobiology B Biology. 258. 113000–113000. 3 indexed citations
7.
He, Hailong, et al.. (2024). A Novel Grading System for Diffuse Chorioretinal Atrophy in Pathologic Myopia. Ophthalmology and Therapy. 13(5). 1171–1184. 2 indexed citations
8.
Chen, Xuan-Yu, Zhuo‐Xun Wu, Jing‐Quan Wang, et al.. (2024). Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cells. Frontiers in Pharmacology. 15. 1400699–1400699. 3 indexed citations
9.
Chen, Xuan-Yu, Hailong He, Jie Xu, Yixin Liu, & Zi‐Bing Jin. (2023). Clinical Features of Fundus Tessellation and Its Relationship with Myopia: A Systematic Review and Meta-analysis. Ophthalmology and Therapy. 12(6). 3159–3175. 4 indexed citations
10.
Kong, Lingyu, Xuan-Yu Chen, Xin Lu, Qinggele Caiyin, & Dong‐Hua Yang. (2023). Association of lung-intestinal microecology and lung cancer therapy. Chinese Medicine. 18(1). 37–37. 13 indexed citations
11.
Chen, Xuan-Yu, Xinyuan Chen, Xintong Yu, et al.. (2023). Cognitive impairment associated with cerebellar volume loss in spinocerebellar ataxia type 3. Journal of Neurology. 271(2). 918–928. 6 indexed citations
12.
He, Hailong, et al.. (2023). Fundus Tessellated Density of Pathologic Myopia. Asia-Pacific Journal of Ophthalmology. 12(6). 604–613. 17 indexed citations
13.
Huang, Zoufang, Saikat Dewanjee, Pratik Chakraborty, et al.. (2023). CAR T cells: engineered immune cells to treat brain cancers and beyond. Molecular Cancer. 22(1). 22–22. 28 indexed citations
14.
Shi, Huijuan, et al.. (2022). Chinese Medicine Formula Siwu-Yin Inhibits Esophageal Precancerous Lesions by Improving Intestinal Flora and Macrophage Polarization. Frontiers in Pharmacology. 13. 812386–812386. 7 indexed citations
15.
Hou, Kejun, Zhuo‐Xun Wu, Xuan-Yu Chen, et al.. (2022). Microbiota in health and diseases. Signal Transduction and Targeted Therapy. 7(1). 135–135. 1744 indexed citations breakdown →
16.
Yuan, Chengxiang, et al.. (2022). Association between malnutrition risk and hemorrhagic transformation in patients with acute ischemic stroke. Frontiers in Nutrition. 9. 993407–993407. 8 indexed citations
17.
Chen, Xuan-Yu, Jing‐Quan Wang, Yuqi Yang, Jing Li, & Zhe‐Sheng Chen. (2021). Natural Product as Substrates of ABC Transporters: A Review. Recent Patents on Anti-Cancer Drug Discovery. 16(2). 222–238. 17 indexed citations
18.
Feng, Weiguo, Meng Zhang, Zhuo‐Xun Wu, et al.. (2020). Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells. Frontiers in Oncology. 10. 955–955. 39 indexed citations
19.
Zhang, Meng, Xuan-Yu Chen, Jing‐Quan Wang, et al.. (2020). NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance. Frontiers in Oncology. 10. 1219–1219. 21 indexed citations
20.
Chen, Xuan-Yu, et al.. (2008). The 14 bp deletion polymorphisms in HLA‐G gene play an important role in the expression of soluble HLA‐G in plasma. Tissue Antigens. 72(4). 335–341. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026